Sorry, an error seems to have occurred. Please, join
to become our member or try log in
again if you are existing member.
Don Sharpe discusses the Payer Perspective on Molecular Testing with Dr. Micheal Kolodziej, MD from Aetna at the COA annual meeting.
2014 has been described by many chronic lymphocytic leukemia (CLL) experts as a pivotal year for developing research and treatment. But are effective therapies in development to treat the full CLL spectrum? Dr. Javier Pinilla-Ibarz, a CLL expert from Moffitt Cancer Center, shares his views and explains the goal of researchers to treat patients with...
7° Riunione Nazionale A.I.G. Associazione Italiana GIST Onlus Bologna, 29 marzo 2014
Managing the side-effect,diarrhea, caused by anti-cancer treatments
Head and Neck Surgeon Ian Ganly describes the value of transoral laser surgery as an alternative to radiation therapy for resection of early-stage laryngeal cancers.
Don Sharpe talks about Molecular Testing for Cancer from a Payer Perspective with Dr. Sundeep Reddy, MD (Caris Life Sciences) at the COA annual meeting.
The world's largest, most respected, and fully accredited kidney cancer charity.
Among kidney cancer patients, the sub-type "non-clear cell" is the least common. As a result, not much research has been conducted on it. GRACEcast 238 Kidney
Eighty percent of lung cancer patients have wild type EGFR, meaning there is no EGFR mutation. Dr. Joan Schiller of UT Southwestern Medical Center discusses a new drug in development that may help those patients. February 2014 GRACEcast 269 Lung
When is it time to consider treatment? How and what symptoms do you communicate to your healthcare team? At our recent MPN Forum in Chicago, Dr. Alison Moliterno, Dr. Brady Stein and Nurse Clinician, Amy Brich, address the questions surrounding treatment considerations. The experts explore the sympt...
Recommended Cancer Videos